Cancer Prevention and Research Institute in Texas. Product Development Research. CPRIT creates and supports infrastructure in Texas that accelerates the movement of new cancer drugs, diagnostics, and therapies. New CLF/CPRIT Cancer Research Project For Pediatric Cancers Funding Awarded.
Researchers RoundUp is hosted by the Carson Leslie foundation together with the 20 year $6 Billion Cancer Prevention and Research Institute of Texas (CPRIT). CPRIT and the Carson Leslie Foundation are rounding up Texas Childhood Brain Cancer Investigators.
The Children’s Brain Tumor Network drives innovative discoveries, pioneers new treatments and accelerates open science to improve the health of every child and young adult diagnosed with a brain tumor.
The Pacific Pediatric Neuro-Oncology Consortium (PNOC) is an international consortium with centers within the United States, Europe, Asia and Australia. We are dedicated to bringing new therapies to children and young adults with brain tumors. Our goal is to improve outcomes by translating the latest findings in brain tumor biology into better treatments for these children.
The Pediatric Brain Tumor Consortium (PBTC) was formed by the National Cancer Institute (NCI) in 1999 to improve the treatment of primary brain tumors in children. The participating academic centers and children’s hospitals are responsible for the diagnosis and treatment of a large percentage of children with primary brain tumors in the United States and Canada.
Collaborative Network for Neuro-Oncology Pediatric Trials
The COllaborative Network for NEuro-oncology Clinical Trials (CONNECT) conducts clinical trials in high-risk pediatric brain tumors to investigate combinations of novel drugs with traditional therapies. We seek to improve outcomes in the worst childhood brain tumors by combining innovative discoveries with “tried and true” therapy regimens.
The Children’s Oncology Group (COG), a National Cancer Institute-supported member group of the National Clinical Trials Network, is the world’s largest, cooperative children’s cancer research entity. With over 10,000 members, it brings together physicians, laboratory scientists, nurses, psychologists and others working to beat cancer in children, adolescents and young adults.
Pediatric Oncology Experimental Therapeutics Investigators’ Consortium, POETIC; To promote early clinical development of promising therapies for children, adolescents, and young adults with cancer and related disorders. By utilizing the expertise and resources of our collaborative network, POETIC offers new possibilities and hope to patients with recurring cancer.
Closer to the Cure is an informative and supportive site with a mission to raise awareness and advance pediatric brain tumor research. We partner with like-minded organizations such to run fundraising events, improve quality of life, and advocate for pivotal legislative action.
At Swifty, we take recurrent medulloblastoma personally. That’s the kind of cancer that took founder, Michael Gustafson’s life – and it’s also a cancer with one of the lowest survival rates. Swifty invests its research grant awards specifically to improve outcomes for children who have recurrent medulloblastoma.
ALSF Childhood Cancer Research Grants has supported many medulloblastoma research initiatives through the co-sponsers. ALSF has been able to fund Medulloblastoma focused research through generous support.
Helping to make an impact on childhood cancer by navigating the regulary landscape through bipartisan support
U.S. Senators Marco Rubio (R-FL) introduced theGabriella Miller Kids First Research Act 2.0. This bipartisan legislation would provide a new source of funding for the National Institutes of Health’s (NIH) Gabriella Miller Kids First Pediatric Research Program.
Congressmen Michael McCaul and Mrs. McCaul invited our founder into their Washington DC home to help launch the Congressional Childhood Cancer Caucus. Since that momentous evening, together with many, we have successfully built an unstoppable force against Childhood Brain Cancer.